Inhibikase Therapeutics, Inc. Common Stock IKT
$1.55
-7.19%
at last close
Financials (TTM)
Trailing-twelve-month financial statements are not available for Inhibikase Therapeutics, Inc. Common Stock (IKT) — this is common for ETFs and funds, which report holdings rather than income statements. See the overview page for price history and key stats.
Key Stats
- Last Close
- $1.55
- Market Cap
- $233.02 million
- 52-Week Range
- $1.33 – $2.61
- Average Volume
- 620K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.